Post date April 10, 2024 Experience Biodesix $55 million follow-on offering The common stock is listed on the Nasdaq Global Market
Post date March 21, 2024 Experience Plug Power private exchange offer A total of $138.8 million aggregate principal amount of existing convertible senior notes were exchanged
Post date March 12, 2024 Experience REGENXBIO $140 million stock and pre-funded warrants offering The stock is listed on the Nasdaq Global Select Market
Post date March 11, 2024 Experience Tyson Foods $1.5 billion senior notes offerings We advised Tyson Foods on its investment-grade notes offering
Post date March 8, 2024 Experience Hamilton Lane $210 million follow-on offering The shares are listed on the Nasdaq Stock Market
Post date March 5, 2024 Experience Perella Weinberg Partners $65 million follow-on offering The shares are listed on Nasdaq
Post date February 27, 2024 Experience AbbVie $15 billion senior notes offering The investment-grade offering comprised seven tranches
Post date February 23, 2024 Experience Bristol Myers Squibb $13 billion notes offering The investment-grade offering comprised nine tranches
Post date February 21, 2024 Experience Prime Medicine $161 million stock and pre-funded warrants offering The common stock is listed on the Nasdaq Global Market
Post date February 21, 2024 Experience Marsh McLennan $1 billion senior notes offering We advised Marsh McLennan on its investment-grade notes offering